Abstract: This invention relates to a cosmetic sponge and a method of providing a cosmetic sponge incorporating a non-denatured collagen and other additives for skin care, cleaning, and cosmetic application.

Abstract: This disclosure relates to a controlled-release composition containing a water-swellable linear polymer together with an active agent. The water-swellable linear polymer is obtained by reacting together: (a) a polyethylene oxide of number average molecular weight less than or equal to 4000 g/mol; (b) an aliphatic diol; and (c) a difunctional isocyanate. The ratio of components (a) to (b) to (c) is in the range of 0.01-0.1 to 1 to 1.01-1.1 in terms of equivalent weights. The amount of the polyethylene oxide is less than 50 wt % of the polymer. The polymer has a water swelling percentage of 20-100%.

Abstract: Compositions and methods are provided for the prevention and treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1? in the wound.

Abstract: Provided is a surface-treated powder, where at least one compound of general formula (1) adheres to the surface of the powder. In formula (1), R2 is a monovalent aromatic hydrocarbon group having 6-12 carbon atoms, R4 is a monovalent non-aromatic hydrocarbon group having 1-30 carbon atoms, R1 and R0 are a group selected from aforementioned groups defined for R2 and R4, and R3 is a group of formula (2), R5 is a divalent hydrocarbon group having 2 to 8 carbon atoms and R6 is an alkyl group having 1 to 6 carbon atoms, a, b, c, and d are integers of from 0-3, 0-200, 1-150, and 0-50, respectively, provided that when a is 0, d and e are integers of from 1-50 and 0-2, respectively, and c/(b+c+d) is 0.25 or more.

Abstract: Methods for treating or preventing one or more symptoms of rheumatoid arthritis or other types of inflammatory arthritis involves administering a formulation containing an effective amount of arsenic trioxide to an affected patient. The arsenic trioxide formulation can be administered orally, for example, as a solution, suspension, syrup, emulsion, tablet, or capsule.

Abstract: The present invention relates to the cosmetic use of an essential oil of Laserpitium siler L., as an active agent for preventing and/or treating skin or keratin disorders associated with constriction of the cutaneous capillary circulation. The invention is also directed towards the cosmetic use of the said essential oil as an active agent for improving the appearance of the lips by increasing the size and/or volume and/or thickness of the lips and/or for (re)modelling them and/or making them smooth, and also to a non-therapeutic cosmetic process for caring for the skin and/or keratin fibers.

Abstract: The present disclosure relates to an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer. The present disclosure also relates to a use of an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer for preventing, combating or controlling pests, particularly insect infestations, by tree injection.

Abstract: The present invention is directed to an anhydrous composition which is long wearing and transfer resistant, while at the same time providing superior comfort, feel and cushioning, the composition containing: (a) at least one polypropylsilsesquioxane wax substituted with alkyl units having at least 30 carbons; (b) at least one siloxysilicate resin; (c) at least one polyorganosiloxane-containing polymer; (d) at least one volatile solvent; (e) optionally, at least one non-volatile solvent; and (f) at least one colorant.

Abstract: The present invention concerns a biomaterial comprising a nanofibrous scaffold made of polymers, such as poly(?-caprolactone) or collagen, coated with at least one layer pair consisting of a layer of polyanions and a layer of polycations, wherein said at least one layer pair incorporates a therapeutic molecule such as a growth factor. The biomaterial may optionally comprise living cells such as osteoblasts and/or chondrocytes.

Abstract: A biocidal and sporicidal smoke composition(s) using iodine oxide and metal powder is provided. This composition generates iodine gas or smoke as the primary biocidal agent, as well as metal oxides that provide additional biocidal properties. The smoke producing composition is suitable for pressing into canisters of compacted powder at a load pressure range of 1500 to 7500 psi and can be used for decontamination of spaces believed to be contaminated with biological agents. The composition is also suitable for use in hand grenades, smoke pots, rifle grenades, mortars, multiple launch grenades, shoulder fired missiles, and artillery rounds, as well as first responder and commercial biological decontamination applications.

Abstract: The present invention provides personal care formulations containing silicone modified polyolefins and having improved sensory feel, as well as being non-tacky and easily spreadable. The present invention also provides a method for treating body surfaces such as skin, hair, nails, etc., by applying the aforesaid personal care formulations externally to such a surface. The present invention also provides a method for improving the sensory feel of personal care formulations by including one or more silicone modified polyolefins in the formulations.

Abstract: Provided is a formulation for oral teeth, which includes a plurality of calcium ion carriers and a plurality of calcium-containing particulates. The particulates are carried by the calcium ion carriers, such that the formulation can prevent or rapidly treat dentin-associated symptoms or diseases, while providing a prolonged prophylactic or therapeutic effect.